Julie Appleby

Visit kff.org to read Julie's bio.

jappleby@kff.org
@Julie_appleby

Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign

The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.

Is Your Living Room the Future of Hospital Care?

In the latest sign that in-home acute care is catching on, two big players — Kaiser Permanente and the Mayo Clinic — announced plans to collectively invest $100 million into the company Medically Home to help scale up their programs.